Search
for
Sort by
Research 931–960 of 1000+
- Eyebrow and Eyelash Alopecia: A Clinical Review
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database
- Alopecia areata
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic review and meta-analysis
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Ex vivo permeation parameters and skin deposition of melatonin-loaded microemulsion for treatment of alopecia
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Gender Differences in Psychosocial Outcomes of Hair Loss Resulting from Childhood Irradiation for Tinea Capitis
- Therapeutic potential of Hibiscusrosa sinensis - A Review
- The role of salivary vitamin D and interleukin-6 on non-scarring Alopecia
- Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- The Economic Burden of Alopecia Areata in Romania
- Platelet-rich plasma in the treatment of alopecia areata: A retrospective evaluation of 17 patients
- Staphylococcus epidermidis Cicaria, a Novel Strain Derived from the Human Microbiome, and Its Efficacy as a Treatment for Hair Loss
- The level of stress and the assessment of selected clinical parameters in patients with androgenetic alopecia.
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Low molecular weight porcine placenta peptide (Placenderm®) as a functional ingredient for hair health: evidence from in vitro and in vivo studies
- Hamamelis virginiana L. in Skin Care: A Review of Its Pharmacological Properties and Cosmetological Applications
- Modulating metal-organic frameworks by surface engineering of stearic acid modification for follicular drug delivery and enhanced hair growth promotion
- Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases
- Analytical determination, antioxidant and anti-inflammatory activities of Bhamrung-Lohit a traditional Thai medicine
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Study of the Thyroid Profile of Patients with Alopecia
- A Comprehensive Review of Microneedling as a Potential Treatment Option for Androgenetic Alopecia
- Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial